What Ventas (VTR) Said on Its Q3 Earnings Call

Ventas NYSE: VTR reported third-quarter results marked by continued growth in its senior housing operating portfolio, increased investment activity and a higher full-year earnings outlook, as the company emphasized demand from an aging U.S. population and limited new senior housing supply.

Chairman and Chief Executive Officer Debra A. Cafaro said the company’s senior housing operating portfolio, or SHOP, remained the principal driver of performance. U.S. SHOP same-store cash net operating income, or NOI, rose 17% year over year, while total company same-store cash NOI increased 11%.

“Our senior housing operating portfolio, now in its fifth year of double-digit organic growth, powered our results,” Cafaro said. She added that Ventas had raised its full-year normalized funds from operations, or FFO, guidance primarily because of its 2026 investment activity.

SHOP occupancy, pricing and margins advance

Executive Vice President of Senior Housing and Chief Investment Officer Justin Hutchens said same-store SHOP cash NOI grew 16% year over year during the quarter, including 17% growth in the U.S. portfolio. SHOP revenue rose 8.3%, supported by occupancy and rate gains.

Average SHOP occupancy increased 120 basis points sequentially and 290 basis points year over year overall. U.S. occupancy rose 320 basis points from a year earlier, led by independent living, where occupancy increased 340 basis points. Ventas said its U.S. SHOP occupancy remained at 89%, which management views as leaving room for further gains.

Revenue per occupied room, or RevPOR, rose 5%, compared with 4.7% in the prior year and 4.4% two years earlier. Hutchens said communities operating at 95% occupancy generated 7% RevPOR growth, while communities at or near full occupancy accounted for 15% of the portfolio, up from 10% in the prior quarter.

Same-store cash NOI margin expanded 190 basis points year over year to 30.7%, with incremental margin flow-through of 53%. Hutchens said an extra day in the third quarter and higher utility costs contributed to a modest sequential margin decline, but said the broader operating-leverage opportunity remained intact.

Ventas attributed its occupancy performance to its operating partners and the Ventas OI data and analytics platform. The company said its SHOP occupancy growth in NIC Top 99 markets exceeded the industry rate by more than double during the quarter, and that cumulative outperformance since the first quarter of 2023 approached 600 basis points.

More than $5 billion of senior housing investments closed

Ventas closed $5.2 billion of investments focused on senior housing year to date, across 37 transactions. The company said its external SHOP growth since the start of 2024 exceeded $10 billion at cost, expanding its SHOP footprint by more than 35%.

Hutchens said the investments are expected to generate projected 10-year unlevered internal rates of return in the double-digit to mid-teens range, with average first-year yields of 6.6%. The acquired properties had an average basis of about $346,000 per unit and were purchased at discounts to estimated replacement costs, according to the company.

The company described the year-to-date acquisitions as approximately 70% luxury local-market leaders, 20% ultra-luxury premium properties and 10% mid-market leaders. Management said it is targeting communities with occupancy and pricing upside, including value-add properties supported by near-term capital expenditures.

Hutchens said more than 90% of investment volume has been sourced through relationships. He said higher debt costs could slow some private buyers and potentially strengthen Ventas’ competitive position, although he noted that it remains early to assess the impact on transaction pricing and cap rates.

Ventas said it is primarily focused on U.S. senior housing acquisitions. Hutchens described the company’s Canadian portfolio as high performing but said the growth profile there was less attractive than in the U.S. The United Kingdom remains of interest but is not currently a major priority, he said.

FFO rises and leverage improves

Chief Financial Officer Bob Probst said normalized FFO totaled $0.99 per share in the third quarter, up 10% from a year earlier. The company’s 11% same-store cash NOI growth rate was a record, he said, reflecting both SHOP’s mid-teens growth and the segment’s expanding contribution to the business.

Ventas’ outpatient medical and research portfolio generated 2.5% same-store cash NOI growth, led by 4% growth in outpatient medical. Outpatient medical occupancy increased 10 basis points year over year, its ninth consecutive quarter of occupancy growth. The company’s triple-net portfolio posted more than 8% same-store cash NOI growth, driven by negotiated rent increases.

Net debt to EBITDA stood at 4.4 times at quarter-end, which Probst described as the company’s strongest leverage level in well over a decade and nearly a full turn better than a year earlier. Ventas funded its year-to-date investment activity with $4.7 billion of equity capital, dispositions and assumed debt, and reported $4.5 billion of liquidity.

Guidance raised again

Ventas raised its full-year net income guidance to $0.64 to $0.67 per share, with a midpoint of $0.66. It also increased normalized FFO guidance to $3.87 to $3.90 per share, representing anticipated year-over-year growth of 9% to 10%.

The new guidance midpoint was $0.01 higher than the previous outlook. Probst said the change reflected a $0.02 benefit from 2026 senior housing investment activity, partly offset by a $0.01 impact from higher interest rates and foreign exchange.

The company reaffirmed same-store cash NOI guidance across its segments and said its outlook includes only the $5.2 billion of investments already closed. Ventas expects most of its planned $700 million of dispositions and loan repayments, at a 7% yield, to close in the fourth quarter.

Cafaro said the company expects demographic demand to support senior housing growth, noting that the baby boomer generation has begun turning 80 and that construction starts for new senior housing units remain low. “We are just now stepping into the period of enormous growth in our customer base,” she said.

About Ventas (NYSE:VTR)

Ventas, Inc NYSE: VTR is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.

Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.